Partial Healing and Physical Function in Pyoderma Gangrenosum: A Framework for Wound Endpoints
- 1 September 2026
- journal article
- research article
- Published by Wiley in Wound Repair and Regeneration
- Vol. 34 (5) , e70222
Abstract
Pyoderma gangrenosum (PG) is a rare, painful ulcerative dermatosis associated with significant functional impairment. Complete w closure is the standard endpoint in wound clinical trials, including PG, but clinically meaningful improvement may occur before total epithelization is achieved. No disease‐specific minimal important difference exists for patient‐reported physical function in PG. We evaluated whether partial healing is associated with differences in physical function and estimated such a threshold using the Skindex‐Mini. This retrospective cohort study included adults with PG receiving dermatologic care at a single academic referral centre between August 2024 and November 2025. Clinical data and patient‐reported outcome measures were obtained from a prospectively maintained PG registry and electronic health records. Healing stage at each visit was categorized as healed, partially healed (≥ 50% reduction in ulcer area) or not healed, and Skindex‐Mini Physical Function scores (0–100 scale, higher scores indicating worse function) were compared using linear mixed‐effects models. The cohort included 80 adults with PG contributing 385 clinical encounters. Physical function scores differed significantly across healing stages ( χ 2 = 39.0; p < 0.001). Compared with unhealed patients, partially healed patients reported better physical function (approximately 17 points lower) and were closer to fully healed patients. A 1‐point improvement in patient global assessment corresponded to an adjusted 20.8‐point improvement in physical function (95% CI, 14.5–27.2; p < 0.001), consistent with distribution‐based estimates. Partially healed patients reported substantially better physical function than unhealed patients, supporting incorporation of patient‐reported physical function and intermediate healing states alongside complete wound closure in PG outcome assessment.Keywords
This publication has 23 references indexed in Scilit:
- The clinical significance of quality of life in pyoderma gangrenosumBritish Journal of Dermatology, 2025
- 59674 Randomized Phase 3 trial of spesolimab in patients with ulcerative pyoderma gangrenosum: A study protocolJournal of the American Academy of Dermatology, 2025
- The Changing Landscape of Clinical Research in Pyoderma GangrenosumJournal of Investigative Dermatology, 2025
- Patient-reported outcomes in patients with peristomal pyoderma gangrenosum: A single-center prospective studyJAAD Case Reports, 2024
- Pain as a Patient-Reported Outcome Measure in Pyoderma GangrenosumJAMA Dermatology, 2023
- Association of All-Cause and Cause-Specific Mortality Risks With Pyoderma GangrenosumJAMA Dermatology, 2023
- Health-related domains of quality of life in pyoderma gangrenosum: A qualitative analysisJournal of the American Academy of Dermatology, 2022
- Daily life after healing of a venous leg ulcer: A lifeworld phenomenological studyInternational Journal of Qualitative Studies on Health and Well-being, 2022
- Opioids for Chronic Noncancer PainJAMA, 2018
- Incidence, Mortality, and Disease Associations of Pyoderma Gangrenosum in the United Kingdom: A Retrospective Cohort StudyJournal of Investigative Dermatology, 2012